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Among  the  family  of  mesenchymatous  tumours,  inﬂammatory  myoﬁbroblastic  tumours
(IMT)  are  an  increasingly  recognised  and  deﬁned  lesional  group  due  to  the  great  many
studies  and  recent  publications.  The  aetiopathogenicity  is  still  not  fully  understood.  It
seems  that  an  immune  origin  is  involved  in  the  pathological  process  [1,2]. These  masses
result  from  the  proliferation  of  ﬁbroblast  and  lymphocyte  cells  associated  with  collagen
wickerwork.  Most  often  benign,  they  may  affect  any  organ  or  supporting  tissue.  However,
these  lesions  remain  non-speciﬁc  and  are  difﬁcult  to  distinguish  from  malignant  tumoral
processes.  Here  resides  the  value  of  imaging:  to  make  the  diagnosis,  guide  the  biopsy
and  thereby  avoid  early  damaging  surgery  or  an  aggressive  medical  treatment.  This  is
all  the  more  valid  since  recent  papers  have  shown  that  corticotherapy  of  short  duration
is  currently  the  ﬁrst  intention  treatment  [2,3]. We  here  describe  the  case  of  a  female
patient  presenting  disseminated  erythematous  lupus  who  presented  a  cervical  myoﬁbrob-
lastic  tumour.  The  early  diagnosis  allowed  for  the  initial  medical  care,  which  turned  out
to  be  effective  without  resorting  to  surgery.
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ase report
 51-year-old  woman  came  to  the  emergency  unit  for
ainless  left  jugal  and  sub-madibular  tumefaction  associ-
ted  with  the  installation,  over  5  days,  of  trismus  that
ecame  irreducible.  In  the  clinical  examination,  the  patient
as  apyretic  and  the  anamnesis  reported  a  past  history
f  disseminated  erythematous  lupus  that  was  diagnosed
any  years  ago,  for  which  her  poor  compliance  with
he  corticotherapy  is  poor.  The  laboratory  tests  detected
n  inﬂammatory  syndrome  without  infection.  An  injected
ervico-encephalic  scan  revealed  a  poorly  deﬁned  inﬁltrat-
ng  mass  that  was  strongly  enhanced  by  the  contrast  product
ithout  washing  late  after  injection.  This  lesion  occupied
he  left  pterygoid-maxillary  fossa  and  extended  to  the  infra-
emporal  region  near  the  left  temporo-mandibular  joint
ithout  bone  lysis  (Fig.  1).  An  MRI  completed  the  description
f  this  lesion  presenting  an  iso-hyposignal  T1,  a  hyposignal
2,  and  with  contrast  enhancement  after  the  injection  of
adolinium  persisting  on  a  late  sequence.  All  this  points  to
 ﬁbrous  component.  On  the  other  hand,  the  examination
istinguished  an  heterogeneity  of  bone  signal  of  inﬂamma-
ory  appearance  without  bone  lysis  (Fig.  1).  The  dysimmune
igure 1. Imaging of the inﬂammatory cervical myoﬁbroblastic tum
xial sections: highly contrasted inﬁltrating mass (black arrow) occupy
nfra-temporal region near the left temporo-mandibular joint without 
ass syndrome in T1 iso-hyposignal (white arrow), hyposignal T2 (tip o
omponent. A left cerebellar ischemic sequence should be noted; d, e: c
helate late after the injection: presence of distinct enhancement of th
rrow) without washing late after the injection; f: PET-scan: lesional hyp
rey arrow).
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redisposition  and  the  atypical  and  mildly  aggressive  radi-
logical  characteristic  suggest  the  diagnosis  of  a  subacute
nﬂammatory  process  rather  than  something  of  malignant
rigin.  Since  the  possibility  of  an  inﬂammatory  myoﬁbrob-
astic  tumour  was  also  mentioned,  a sono-guided  biopsy  was
arried  out.  By  histology,  the  latter  conﬁrmed  the  diagno-
is  of  IMT  (Fig.  2).  In  the  extension  assessment,  a  PET-scan
elped  eliminate  other  synchronous  locations  (Fig.  1).  In
iew  of  the  anatomo-pathological  results,  the  ﬁrst  inten-
ion  treatment  consisted  of  corticotherapy  for  1  month.  The
ontrol  by  scanner  at  the  end  of  treatment  showed  the  dis-
ppearance  of  the  enhancement  of  the  contrast  product
Fig.  3).  The  other  controls  after  3  and  6  months  and  1
ear  did  not  detect  any  recurrence.  During  this  period,  the
atient  presented  good  compliance  with  her  basic  treatment
or  her  connectivitis.
iscussionour. a: cervical TDM with injection of iodine contrast product in
ing the left pterygoido-maxillary fossa and extending to the left
bone lysis; b, c: cervical MRI axial sections T1, T2: revealing the
f white arrow) without peri-lesional oedema resembling a ﬁbrous
ervical MRI axial, coronal sections T1 after injection of gadolinium
e mass in coronal section (star) and axial section (black tip of the
erﬁxation without other synchronous location at a distance (tip of
MT  are  a  sub-group  of  mesenchymatous  lesions  that  may
ffect  adults  and  children.  The  IMT  are  currently  a  separate
ntity  deﬁned  by  clinical,  radiological,  histopathological
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Figure 2. Histo-anapathological sections of the sample taken by sono-guided biopsy: a: HES (× 20): Inﬂammatory lymphocytary inﬁltrate
issue to the striated muscle ﬁbres; c: immunohistochemisty with actin:in the collagen tissue; b: HES (× 20): extension of the connective t
labelling of fusiform cells.
and  molecular  criteria  [4,5]. They  result  from  the  pro-
liferation  of  fusiform  cells  on  myxoid  background  and  an
inﬂammatory  component.  The  diagnosis  is  conﬁrmed  by  the
anatomopathology  that  detects  the  myoﬁbroblastic  nature
of  the  cells,  positive  in  70  to  90%  of  all  cases  of  smooth
muscle  actina  and  in  40  to  70%  of  all  cases  of  desmina  and
calponina  [4,5]. These  lesions  may  affect  all  parts  of  the
body.  They  predominate  in  the  lungs  and  orbits.  A  cervi-
cal  location  is  rare.  It  develops  more  often  in  men.  IMT  are
lesions  with  a  low  degree  of  malignancy  and  little  recur-
rence  and  metastasis  (under  10%)  [4,5]. Clinically,  chronic
inﬂammatory  tumefaction  is  described,  rarely  accompa-
nied  by  systemic  manifestations  such  as  fever,  weight  loss,
anaemia,  hypergammaglobulinemia  or  an  increase  in  the
sedimentation  rate  [6].  The  pathogenicity  is  still  not  fully
clear  although  a  dysimmune  context  seems  to  be  a pre-
disposing  factor  (connectivitis,  infection  by  Epstein  Barr
virus  or  herpes  8)  [1,2]. As  far  as  we  are  aware,  only
was  case  has  been  reported  in  the  literature,  represent-
ing  the  second  case  of  IMT  associated  with  disseminated
erythemateous  lupus  [7].  Imaging  is  included  in  all  stages
of  the  care  of  this  lesion:  descriptive  stage  (locoregional
extension),  analytical  stage  (suggestion  of  the  differential
diagnoses)  and  interventional  stage  (guiding  of  the  biopsy).
Figure 3. Control after 1 month: cervical scan with injection
of iodine contrast product. Absence of contrast within the mass
attesting to a good response to the medical treatment (tip of black
arrow).
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hese  lesions  remain  non-speciﬁc  and  may  resemble  lym-
homatous  lesions,  nasopharyngeal  carcinoma  or  Wegener’s
ranulomatosis  [2].  Nevertheless,  certain  characteristics
rient  the  diagnosis  to  cervical  locations:  the  topogra-
hy,  rather  at  the  level  of  the  infra-temporal  fosa,  the
terygopalatin  space  and  opposite  the  temporo-mandibular
oint.  The  scan  is  non-speciﬁc  and  detects  a  homogenous
r  heterogeneous  hypo,  iso  or  hyperdense  lesion  taking
p  the  contrast  that  persists  long  after  injection.  The
RI  presents  more  speciﬁc  criteria:  an  hypointense  T1
nd  T2  signal  associated  with  distinct  enhancement  per-
isting  late  after  the  injection  calling  to  mind  a  ﬁbrous
omponent,  possibly  accompanied  by  inﬂammation  of  the
pposite  bone  structures  without  lysis  such  as  bone  signal
eterogenicity  [1,8—10]. These  non-speciﬁc  characteristics
ake  an  aggressive  process  less  certain  and  rather  indicate
 chronic  inﬂammatory  phenomenon.  The  PET-scan  con-
ributes  to  the  assessment  of  extension  in  the  search  for
ther  synchronous  locations.  Mention  of  this  diagnosis  and
ecognition  of  these  lesions  during  the  pre-surgical  period
re  fundamental.  This  avoids  immediate  damaging  surgery
hat  is  often  not  indicated.  This  agrees  with  the  recent
apers  demonstrating  spontaneous  regressions  or  regres-
ions  with  medical  treatment.  Moreover,  corticotherapy  is
urrently  recognised  as  the  ﬁrst  intention  treatment  after
istological  proof,  necessary  in  pre-therapy  due  to  the  exis-
ence  of  differential  diagnoses  [2,3]. The  most  aggressive
ortico-sensitive  lesions  may  resemble  IMT,  ﬁrst  of  all  the
ymphomas.
onclusionMT  are  rare  lesions,  especially  at  the  cervical  level.  They
ay  resemble  malignant  tumours  although  certain  speciﬁc
eatures  in  imaging  help  point  out  the  diagnosis  and  thereby
rient  care  towards  a  less  aggressive  approach.
[W.  Marraoui  et  al.
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